Hematology status update: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{CMG}}; {{AE}} {{Hudakarman}}
{{CMG}}; {{AE}} {{Hudakarman}}
{{Organ System Project}}
{{Organ System Project}}
System Leader: '''[[User:Ramyar Ghandriz|Ramyar Ghandriz, M.D.]]'''
System Leader: '''[[User:Ramyar Ghandriz|Ramyar Ghandriz, M.D.]]'''
== Status Updates ==
==Status Updates==
{| border="1" cellpadding="5" cellspacing="0" align="center" |class="wikitable"class="wikitable"
{| class="wikitable" border="1" cellpadding="5" cellspacing="0" align="center" |class="wikitable"
|+
|+
! colspan="2" style="background:#efefef;" |Resident survival guide Progress
! colspan="2" style="background:#efefef;" |Resident survival guide Progress
|-
|-
|Completed
|Completed
|
|
|-
|-
|In progress  
|In progress
|
|
|-
|-
|Remaining  
|Remaining
|
|
|-
|-
! colspan="2" style="background:#efefef;" |Primary care chapter Progress
! colspan="2" style="background:#efefef;" |Primary care chapter Progress
|-
|-
|Completed
|Completed
|
|
|-
|-
|In progress  
|In progress
|
|
|-
|-
|Remaining  
|Remaining
|
|
|}
|}
Line 34: Line 35:
! colspan="3" |Primary care resident survival guides
! colspan="3" |Primary care resident survival guides
|-
|-
! Specialty
!Specialty
! Topic
!Topic
!Author
!Status
!Resident Survival Guide Page
!Author
!Author
!Status
!Status
! Resident Survival Guide Page
! Author
! Status
|-
|-
|Hematology
|Hematology
Line 58: Line 59:
|
|
|-
|-
| Hematology ||[[Anemia]]
|Hematology||[[Anemia]]
|
|
| ||[[Anemia resident survival guide]]|| Chetan ||Needs Review
| ||[[Anemia resident survival guide]]||Chetan||Needs Review
|-
|-
|Hematalogy
|Hematalogy
Line 86: Line 87:
|
|
|-
|-
| Hematology ||[[Aplastic anemia]]
|Hematology||[[Aplastic anemia]]
|
|
| ||[[Aplastic anemia resident survival guide]]|| Chetan ||Needs Review
| ||[[Aplastic anemia resident survival guide]]||Chetan||Needs Review
|-
|-
| Hematology ||[[Hemolytic anemia]]
|Hematology||[[Hemolytic anemia]]
|
|
| ||[[Hemolytic anemia resident survival guide]]||Sanjana
| ||[[Hemolytic anemia resident survival guide]]||Sanjana
|Needs English Review
|Needs English Review
|-
|-
| Hematology ||[[Heparin induced thrombocytopenia]]
|Hematology||[[Heparin induced thrombocytopenia]]
|
|
| ||[[HIT resident survival guide]]|| Karol|| Needs Review
| ||[[HIT resident survival guide]]||Karol||Needs Review
|-
|-
|Hematology
|Hematology
Line 105: Line 106:
|[[Immune Thrombocytopenia resident survival guide]]
|[[Immune Thrombocytopenia resident survival guide]]
|Iqra
|Iqra
| -
| -
|-
|-
|Hematology
|Hematology
Line 123: Line 124:
|
|
|-
|-
| Hematology ||[[Pancytopenia]]
|Hematology||[[Pancytopenia]]
|
|
| ||[[Pancytopenia resident survival guide]]|| ||
| ||[[Pancytopenia resident survival guide]]|| ||
|-
|-
| Hematology ||[[Thrombocytopenia]]
|Hematology||[[Thrombocytopenia]]
|
|
| ||[[Thrombocytopenia resident survival guide]]||Ogheneochuko|| Complete
| ||[[Thrombocytopenia resident survival guide]]||Ogheneochuko||Complete
|-
|-
| Hematology ||[[Febrile neutropenia]]
|Hematology||[[Febrile neutropenia]]
|
|
| ||[[Febrile neutropenia resident survival guide]]|| Rim ||Complete
| ||[[Febrile neutropenia resident survival guide]]||Rim||Complete
|-
|-
| Hematology ||[[Bleeding disorders]]
|Hematology||[[Bleeding disorders]]
|
|
| ||[[Bleeding disorder resident survival guide]]|| ||
| ||[[Bleeding disorder resident survival guide]]|| ||
|-
|-
| Hematology ||[[DIC]]
|Hematology||[[DIC]]
|
|
| ||[[DIC resident survival guide]]||Ogheneochuko|| Complete
| ||[[DIC resident survival guide]]||Ogheneochuko||Complete
|-
|-
| Hematology ||[[Transfusion therapy]]
|Hematology||[[Transfusion therapy]]
|
|
| ||[[Transfusion therapy resident survival guide]]||Ayokunle||Complete
| ||[[Transfusion therapy resident survival guide]]||Ayokunle||Complete
Line 150: Line 151:


==Status Update==
==Status Update==
{| border="1" cellpadding="5" cellspacing="0" align="center" |class="wikitable"class="wikitable"
{| class="wikitable" border="1" cellpadding="5" cellspacing="0" align="center" |class="wikitable"
|+
|+
! colspan="2" style="background:#efefef;" |Progress
! colspan="2" style="background:#efefef;" |Progress
|-
|-
|Completed
|Completed
|4
|4
|-
|-
|In progress  
|In progress
|4
|4
|-
|-
|Remaining  
|Remaining
|16
|16
|}
|}
== List of Chapters Requiring Content ==
==List of Chapters Requiring Content==
{| style="border: 0px; font-size: 90%; margin: 3px;" align="center"
{| style="border: 0px; font-size: 90%; margin: 3px;" align="center"
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Category}}
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Category}}
Line 176: Line 177:
| rowspan="25" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Hematology
| rowspan="25" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Hematology
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Acanthocytosis
*Acanthocytosis


*
*
Line 206: Line 207:
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* [[ACUITY HORIZONS bleeding criteria]]
*[[ACUITY HORIZONS bleeding criteria]]


*
*
Line 220: Line 221:
*
*
*[[Purpura]]
*[[Purpura]]
** Papular  
**Papular
** Infectious  
**Infectious
**[[Purpura fulminans]]
**[[Purpura fulminans]]
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 249: Line 250:
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* [[Acute megakaryoblastic leukemia]]
*[[Acute megakaryoblastic leukemia]]
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 258: Line 259:
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
*[[Neutrophilia]]  
*[[Neutrophilia]]
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 267: Line 268:
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* [[Autoimmune lymphoproliferative syndrome]]
*[[Autoimmune lymphoproliferative syndrome]]
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 276: Line 277:
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
*[[Lymphocytosis]]  
*[[Lymphocytosis]]
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 285: Line 286:
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
*[[Monocytosis]]  
*[[Monocytosis]]
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 303: Line 304:
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* [[Basophilia]]
*[[Basophilia]]
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 312: Line 313:
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
*  
*
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 321: Line 322:
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* [[Castleman's disease]]
*[[Castleman's disease]]


*
*
Line 332: Line 333:
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* [[Evans syndrome]]
*[[Evans syndrome]]
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 341: Line 342:
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* [[Asplenia]]
*[[Asplenia]]
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 431: Line 432:
| rowspan="22" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Hematology
| rowspan="22" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Hematology
| style="padding: 5px 5px; background: #F5F5F5;" |[[Hemophilia]]  
| style="padding: 5px 5px; background: #F5F5F5;" |[[Hemophilia]]  
*[[Hemophilia A (patient information)|Hemophilia A]]
*[[Hemophilia A (patient information)|Hemophilia A]]
*[[Hemophilia B (patient information)|Hemophilia B]]
*[[Hemophilia B (patient information)|Hemophilia B]]
Line 443: Line 443:
| style="padding: 5px 5px; background: #F5F5F5;" |<br />
| style="padding: 5px 5px; background: #F5F5F5;" |<br />


* [[22q11.2 deletion syndrome]]
*[[22q11.2 deletion syndrome]]
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Ayushi Jane
| style="padding: 5px 5px; background: #F5F5F5;" |Ayushi Jane
Line 452: Line 452:
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* [[Anemia of prematurity]]
*[[Anemia of prematurity]]
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Asra Firdous
| style="padding: 5px 5px; background: #F5F5F5;" |Asra Firdous
| style="padding: 5px 5px; background: #F5F5F5;" |Ramyar
| style="padding: 5px 5px; background: #F5F5F5;" |Ramyar
| style="padding: 5px 5px; background: #F5F5F5;" |In progress
| style="padding: 5px 5px; background: #F5F5F5;" |Complete
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 462: Line 462:
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* [[Myelophthisic anemia]]
*[[Myelophthisic anemia]]
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Mahda
| style="padding: 5px 5px; background: #F5F5F5;" |Mahda
Line 471: Line 471:
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* [[Diamond-Blackfan anemia]]
*[[Diamond-Blackfan anemia]]


*  
*
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Roghiae Marandi
| style="padding: 5px 5px; background: #F5F5F5;" |Roghiae Marandi
Line 652: Line 652:
| rowspan="22" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Hematology
| rowspan="22" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Hematology
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* [[Antithrombin III deficiency]]
*[[Antithrombin III deficiency]]
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Sogand, M.khuram afzal
| style="padding: 5px 5px; background: #F5F5F5;" |Sogand, M.khuram afzal
Line 661: Line 661:
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* [[Neutropenia]]
*[[Neutropenia]]
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" | Daniel A. Gerber
| style="padding: 5px 5px; background: #F5F5F5;" |Daniel A. Gerber
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Complete
| style="padding: 5px 5px; background: #F5F5F5;" |Complete
Line 670: Line 670:
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* [[Cancer]]
*[[Cancer]]
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 680: Line 680:
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* [[Fanconi anemia]]
*[[Fanconi anemia]]


*
*

Revision as of 19:52, 28 August 2020


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Huda A. Karman, M.D.

Organ System Project
Topics
Leaders & Members
Meetings' Summary

System Leader: Ramyar Ghandriz, M.D.

Status Updates

Resident survival guide Progress
Completed
In progress
Remaining
Primary care chapter Progress
Completed
In progress
Remaining

Primary Care

Primary care chapter Primary care resident survival guides
Specialty Topic Author Status Resident Survival Guide Page Author Status
Hematology Easy bruising Easy bruising resident survival guide Sanjana Needs English Review
Hematology Thrombophilia Thrombophilia resident survival guide Rina Ghorpade
Hematology Anemia Anemia resident survival guide Chetan Needs Review
Hematalogy Fatigue Fatigue resident survival guide Monika, Tayyeba
Hematalogy Pica Pica resident survival guide Sanjana
Hematology Polycythemia Polycythemia resident survival guide Alieh Behjat
Hematology Aplastic anemia Aplastic anemia resident survival guide Chetan Needs Review
Hematology Hemolytic anemia Hemolytic anemia resident survival guide Sanjana Needs English Review
Hematology Heparin induced thrombocytopenia HIT resident survival guide Karol Needs Review
Hematology Immune Thrombocytopenia Immune Thrombocytopenia resident survival guide Iqra -
Hematology VTE VTE prevention resident survival guide
Hematology Acute Leukemia Acute leukemia resident survival guide Iqra
Hematology Pancytopenia Pancytopenia resident survival guide
Hematology Thrombocytopenia Thrombocytopenia resident survival guide Ogheneochuko Complete
Hematology Febrile neutropenia Febrile neutropenia resident survival guide Rim Complete
Hematology Bleeding disorders Bleeding disorder resident survival guide
Hematology DIC DIC resident survival guide Ogheneochuko Complete
Hematology Transfusion therapy Transfusion therapy resident survival guide Ayokunle Complete


Status Update

Progress
Completed 4
In progress 4
Remaining 16

List of Chapters Requiring Content

Category Chapters that need content Assignment Status Scholar's name Coach name Completion Status Review status Reviewer name
Hematology
  • Acanthocytosis

In progress chapters

Category Chapters that need content Assignment Status Scholar's name Coach name Completion Status Review status Reviewer name
Hematology Hemophilia Assigned Muhammad Adnan Heider Abdelrahman In progress

Assigned Ayushi Jane Ramyar In progress
Assigned Asra Firdous Ramyar Complete
Assigned Mahda In progress
Assigned Roghiae Marandi Musadiq In progress

Completed chapters

Category Chapters that need content Assignment Status Scholar's name Coach name Completion Status Review status Reviewer name
Hematology Sogand, M.khuram afzal Complete Needs Review Ramyar
Daniel A. Gerber Complete Needs Review
Complete Needs Review
Shayam Patel Complete Needs Review